SCHEMBL29757183

SCHEMBL29757183

Nc1cccc2c1C(O)c1ccccc1C2=O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EDNRB P24530 9/20 0.46
EDNRA P25101 9/20 0.46
ADORA2A P29274 2/20 0.46
PTPRC P08575 1/20 0.42
MAPK1 P28482 2/20 0.40
CYP1A2 P05177 1/20 0.40
MAOA P21397 2/20 0.37
FGR P09769 1/20 0.37
PIM1 P11309 1/20 0.37
CSNK1A1 P48729 1/20 0.37
CSNK1D P48730 1/20 0.37
DYRK1A Q13627 1/20 0.37
HIPK2 Q9H2X6 1/20 0.37
CSNK1G1 Q9HCP0 1/20 0.37
MEN1 O00255 1/20 0.37
CDC25B P30305 1/20 0.37
KMT2A Q03164 1/20 0.37
HTR2B P41595 1/20 0.36
MAOB P27338 1/20 0.36
ALDH1A1 P00352 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16970851 1.00 EDNRB (0.46) EDNRBEDNRAADORA2APTPRCMAPK1
SCHEMBL1077190 0.85 ALDH1A1 (0.41) ADORA2APTPRCMEN1KMT2AHTR2B
SCHEMBL5436457 0.79 EDNRB (0.55) EDNRBEDNRAPTPRCMAPK1CYP1A2
SCHEMBL27935289 0.77 ALDH1A1 (0.50) PTPRCMEN1KMT2AHTR2BALDH1A1
SCHEMBL10632615 0.76 ALDH1A1 (0.56) EDNRBEDNRAPTPRCMAPK1CYP1A2
SCHEMBL11663620 0.71 EDNRB (0.47) EDNRBEDNRAPTPRCMAPK1CYP1A2
SCHEMBL10635317 0.70 CYP1A2 (0.53) EDNRBEDNRAMAPK1CYP1A2MAOA
SCHEMBL19772569 0.68 EDNRB (0.44) EDNRBEDNRAPTPRCMAPK1CYP1A2
SCHEMBL18721606 0.68 ADORA2A (0.45) EDNRBEDNRAADORA2AMAPK1CYP1A2
SCHEMBL6418811 0.67 MAOA (0.57) MAPK1MAOACSNK1A1CSNK1DCSNK1G1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109820853-B Use of substituted heterocyclic compounds for the treatment of cancer VM肿瘤药物有限责任公司 2022-05-10 CN disclosed